2021 was an important year for Vertex and one that positioned the company well for the future as they continued to discover, develop and commercialize transformative medicines for people with serious diseases while demonstrating an unwavering commitment to corporate responsibility.
From increasing access to its cystic fibrosis medicines for thousands more patients, to continuing to integrate sustainability best practices into its operations and supporting education, innovation and health, Vertex’s 2021 achievements are the result of its employees, patients and communities working together.
Contact:
Sarah D’Souza, 857-329-8495
In their newly released 2021 annual Corporate Responsibility report, Vertex highlights the progress made across their core focus areas including Inclusion, Diversity & Equity, Environmental Sustainability, Community Engagement, and Commitment to Patients.
